{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:19:24Z","timestamp":1792621164382,"version":"4.5.0"},"reference-count":53,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.csbj.2023.01.023","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T23:11:07Z","timestamp":1674169867000},"page":"1102-1114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Semi-automated\n                    <sup>18<\/sup>\n                    F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation"],"prefix":"10.34133","volume":"21","author":[{"given":"Kylie","family":"Keijzer","sequence":"first","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"},{"name":"Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne G.H.","family":"Niezink","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke W.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A.","family":"van Doesum","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Meerten","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne V.","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/bloodadvances.2019001201","article-title":"SAKK38\/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model","volume":"4","author":"Ceriani L.","year":"2020","unstructured":"Ceriani L., Gritti G., Cascione L., Pirosa M.C., Polino A., Ruberto T. et al: SAKK38\/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Adv 2020; 4: 1082.","journal-title":"Blood Adv"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","article-title":"Relapsed\/refractory diffuse large B-cell lymphoma","volume":"2011","author":"Friedberg J.W.","year":"2011","unstructured":"Friedberg J.W.: Relapsed\/refractory diffuse large B-cell lymphoma. Hematology 2011; 2011: 498.","journal-title":"Hematology"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","unstructured":"Meignan M. Gallamini A. and Haioun C.: Report on the first international workshop on interim-PET scan in lymphoma. Https:\/\/DoiOrg\/101080\/10428190903040048 2009; 50: 1257.","DOI":"10.1080\/10428190903040048"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149072","article-title":"Inter-reader reliability of early FDG-PET\/CT response assessment using the deauville scale after 2 cycles of intensive chemotherapy (OEPA) in Hodgkin\u2019s Lymphoma","volume":"11","author":"Kluge R.","year":"2016","unstructured":"Kluge R., Chavdarova L., Hoffmann M., Kobe C., Malkowski B., Montravers F. et al: Inter-reader reliability of early FDG-PET\/CT response assessment using the deauville scale after 2 cycles of intensive chemotherapy (OEPA) in Hodgkin\u2019s Lymphoma. PLoS One 2016; 11: e0149072.","journal-title":"PLoS One"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","article-title":"qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma","volume":"41","author":"Hasenclever D.","year":"2014","unstructured":"Hasenclever D., Kurch L., Mauz-K\u00f6rholz C., Elsner A., Georgi T., Wallace H. et al: qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging 2014; 41: 1301.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_7_2","article-title":"18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study","volume":"121","author":"Burggraaff C.N.","year":"2021","unstructured":"Burggraaff C.N., Eertink J.J., Lugtenburg P.J., Hoekstra O.S., Arens A.I.J., Keizer B. de et al: 18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study. (jnumed) J Nucl Med 2021; 121: 262205.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","article-title":"Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL","volume":"43","author":"Mikhaeel N.G.","year":"2016","unstructured":"Mikhaeel N.G., Smith D., Dunn J.T., Phillips M., M\u00f8ller H., Fields P.A. et al: Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging 2016; 43: 1209.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/jcm11061522","article-title":"Value of CT-textural features and volume-based PET parameters in comparison to serologic markers for response prediction in patients with diffuse large B-cell lymphoma undergoing CD19-CAR-T cell therapy","volume":"11","author":"Reinert C.P.","year":"2022","unstructured":"Reinert C.P., Perl R.M., Faul C., Lengerke C., Nikolaou K., Dittmann H. et al: Value of CT-textural features and volume-based PET parameters in comparison to serologic markers for response prediction in patients with diffuse large B-cell lymphoma undergoing CD19-CAR-T cell therapy. Vol 11, Page 1522 2022 J Clin Med 2022; 11: 1522.","journal-title":"J Clin Med"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2019.09.027","article-title":"Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: post-hoc analysis from the PETAL trial","volume":"124","author":"Schmitz C.","year":"2020","unstructured":"Schmitz C., H\u00fcttmann A., M\u00fcller S.P., Hanoun M., Boellaard R., Brinkmann M. et al: Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: post-hoc analysis from the PETAL trial. Eur J Cancer 2020; 124: 25.","journal-title":"Eur J Cancer"},{"key":"e_1_3_5_11_2","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1007\/s00330-020-06815-8","article-title":"Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy","volume":"30","author":"Aide N.","year":"2020","unstructured":"Aide N., Fruchart C., Nganoa C., Gac A.C. and Lasnon C.: Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy. Eur Radio 2020; 30: 4623.","journal-title":"Eur Radio"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/annonc\/mdw011","article-title":"Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET\/CT in patients with peripheral T-cell lymphoma (PTCL","volume":"27","author":"Cottereau","year":"2016","unstructured":"Cottereau , Becker S., Broussais F., Casasnovas O., Kanoun S., Roques M. et al: Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET\/CT in patients with peripheral T-cell lymphoma (PTCL. Ann Oncol 2016; 27: 719.","journal-title":"Ann Oncol"},{"key":"e_1_3_5_13_2","first-page":"34","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","author":"Meignan M.","year":"2016","unstructured":"Meignan M., Cottereau A.S., Versari A., Chartier L., Dupuis J., Boussetta S. et al: Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies. J Clin Oncol 2016; : 34.","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.21.02063","article-title":"Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index","volume":"40","author":"Mikhaeel N.G.","year":"2022","unstructured":"Mikhaeel N.G., Heymans M.W., Eertink J.J., de Vet H.C.W., Boellaard R., D\u00fchrsen U. et al: Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index. J Clin Oncol 2022; 40: 2352.","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.08.037","article-title":"Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer","volume":"61","author":"Paulino A.C.","year":"2005","unstructured":"Paulino A.C., Koshy M., Howell R., Schuster D. and Davis L.W.: Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol*Biol*Phys 2005; 61: 1385.","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"e_1_3_5_16_2","first-page":"328","volume-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","author":"Boellaard R.","year":"2015","unstructured":"Boellaard R., Delgado-Bolton R., Oyen W.J.G., Giammarile F., Tatsch K., Eschner W. et al: FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. : 2015: 328."},{"key":"e_1_3_5_17_2","first-page":"468","article-title":"Automatic image segmentation by positioning a seed. Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)","author":"Mi\u010du\u0161\u00edk B.","year":"2006","unstructured":"Mi\u010du\u0161\u00edk B. and Hanbury A.: Automatic image segmentation by positioning a seed. Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 3952 LNCS 2006; : 468.","journal-title":"3952 LNCS"},{"key":"e_1_3_5_18_2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00259-018-3953-z","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","volume":"45","author":"Ilyas H.","year":"2018","unstructured":"Ilyas H., Mikhaeel N.G., Dunn J.T., Rahman F., M\u00f8ller H., Smith D. et al: Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging 2018; 45: 1142.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2967\/jnumed.119.227249","article-title":"Time to prepare for risk adaptation in lymphoma by standardizing measurement OF METABOLIC TUMOr Burden","volume":"60","author":"Barrington S.F.","year":"2019","unstructured":"Barrington S.F. and Meignan M.: Time to prepare for risk adaptation in lymphoma by standardizing measurement OF METABOLIC TUMOr Burden. J Nucl Med 2019; 60: 1096.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","article-title":"Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL","volume":"43","author":"Mikhaeel N.G.","year":"2016","unstructured":"Mikhaeel N.G., Smith D., Dunn J.T., Phillips M., M\u00f8ller H., Fields P.A. et al: Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging 2016; 43: 1209.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","article-title":"Lymphoid neoplasia: noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing","volume":"125","author":"Kurtz D.M.","year":"2015","unstructured":"Kurtz D.M., Green M.R., Bratman S. v, Scherer F., Liu C.L., Kunder C.A. et al: Lymphoid neoplasia: noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood 2015; 125: 3679.","journal-title":"Blood"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.V130.Suppl_1.824.824","article-title":"Baseline PET-derived metabolic tumor volume metrics predict progression-free and overall survival in DLBCL after first-line treatment: results from the phase 3 GOYA Study","volume":"130","author":"Kostakoglu L.","year":"2017","unstructured":"Kostakoglu L., Martelli M., Sehn L.H., Belada D., Carella A.-M., Chua N. et al: Baseline PET-derived metabolic tumor volume metrics predict progression-free and overall survival in DLBCL after first-line treatment: results from the phase 3 GOYA Study. Blood 2017; 130: 824.","journal-title":"Blood"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1158\/1078-0432.CCR-15-2825","article-title":"Molecular profile and FDG-PET\/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma","volume":"22","author":"Cottereau A.S.","year":"2016","unstructured":"Cottereau A.S., Lanic H., Mareschal S., Meignan M., Vera P., Tilly H. et al: Molecular profile and FDG-PET\/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma. Clin Cancer Res 2016; 22: 3801.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-826958"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/annonc\/mdw011","article-title":"Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET\/CT in patients with peripheral T-cell lymphoma (PTCL","volume":"27","author":"Cottereau","year":"2016","unstructured":"Cottereau , Becker S., Broussais F., Casasnovas O., Kanoun S., Roques M. et al: Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET\/CT in patients with peripheral T-cell lymphoma (PTCL. Ann Oncol 2016; 27: 719.","journal-title":"Ann Oncol"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2012.05.001"},{"key":"e_1_3_5_27_2","first-page":"242","article-title":"Python 3 Reference Manual; CreateSpace","author":"van Rossum G.","year":"2009","unstructured":"van Rossum G. and Drake F.L.: Python 3 Reference Manual; CreateSpace. Scotts Val, CA 2009; : 242.","journal-title":"Scotts Val, CA"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl R.L.","year":"2009","unstructured":"Wahl R.L., Jacene H., Kasamon Y. and Lodge M.A.: From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50: 122S.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199605000-00005"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(00)00396-8"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(01)00126-3"},{"key":"e_1_3_5_32_2","unstructured":"Waxman A.D. Herholz K. Lewis D.H. Herscovitch P. Minoshima S. Ichise M. et al. Society of Nuclear Medicine Procedure Guideline for FDG PET Brain Imaging n.d."},{"key":"e_1_3_5_33_2","first-page":"1","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts HJWL","year":"2014","unstructured":"Aerts HJWL , Velazquez E.R., Leijenaar R.T.H., Parmar C., Grossmann P., Cavalho S. et al: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014 5:1 2014; 5: 1.","journal-title":"Nat Commun 2014 5:1"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s00259-008-0874-2","article-title":"The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials","volume":"35","author":"Boellaard R.","year":"2008","unstructured":"Boellaard R., Oyen W.J.G., Hoekstra C.J., Hoekstra O.S., Visser E.P., Willemsen A.T. et al: The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008; 35: 2320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_35_2","unstructured":"Multi Atlas M.R. contouring automation | Embrace MR n.d. \u3008https:\/\/mirada-medical.com\/product\/embrace-mr-multi-atlas-contouring\/\u3009."},{"key":"e_1_3_5_36_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13550-022-00916-9","article-title":"Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods","volume":"12","author":"Ferr\u00e1ndez M.C.","year":"2022","unstructured":"Ferr\u00e1ndez M.C., Eertink J.J., Golla S.S.V., Wiegers S.E., Zwezerijnen G.J.C., Pieplenbosch S. et al: Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods. EJNMMI Res 2022; 12: 44.","journal-title":"EJNMMI Res"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2967\/jnumed.121.262117","article-title":"Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?","volume":"63","author":"Eertink J.J.","year":"2022","unstructured":"Eertink J.J., Pfaehler E.A.G., Wiegers S.E., van de Brug T., Lugtenburg P.J., Hoekstra O.S. et al: Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?. J Nucl Med 2022; 63: 389.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2967\/jnumed.120.258673","article-title":"Shaban EAIN, Pieplenbosch S, et al. Interobserver agreement on automated metabolic tumor volume measurements of deauville score 4 and 5 Lesions at Interim 18F-FDG PET in diffuse large B-Cell Lymphoma","volume":"62","author":"Zwezerijnen G.J.C.","year":"2021","unstructured":"Zwezerijnen G.J.C., Eertink J.J., Burggraaff C.N. and Wiegers S.E.: Shaban EAIN, Pieplenbosch S, et al. Interobserver agreement on automated metabolic tumor volume measurements of deauville score 4 and 5 Lesions at Interim 18F-FDG PET in diffuse large B-Cell Lymphoma. J Nucl Med 2021; 62: 1531.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2967\/jnumed.119.238923","article-title":"Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful? a study on behalf of the PETRA consortium","volume":"62","author":"Barrington S.F.","year":"2021","unstructured":"Barrington S.F., Zwezerijnen B.G.J.C., de Vet H.C.W., Heymans M.W., Mikhaeel N.G., Burggraaff C.N. et al: Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful? a study on behalf of the PETRA consortium. J Nucl Med 2021; 62: 332.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_40_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo11020072","article-title":"Reproducibility of baseline tumour metabolic volume measurements in diffuse large b-cell lymphoma: is there a superior method?","volume":"11","author":"Eude F.","year":"2021","unstructured":"Eude F., Toledano M.N., Vera P., Tilly H., Mihailescu S.D. and Becke S.: Reproducibility of baseline tumour metabolic volume measurements in diffuse large b-cell lymphoma: is there a superior method?. Metabolites 2021; 11: 1.","journal-title":"Metabolites"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abb6bd","article-title":"Comparison of 11 automated PET segmentation methods in lymphoma","volume":"65","author":"Weisman A.J.","year":"2020","unstructured":"Weisman A.J., Kieler M.W., Perlman S., Hutchings M., Jeraj R., Kostakoglu L. et al: Comparison of 11 automated PET segmentation methods in lymphoma. Phys Med Biol 2020; 65: 235019.","journal-title":"Phys Med Biol"},{"key":"e_1_3_5_42_2","first-page":"340","article-title":"Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with 18F-FDG PET\/CT, in patients with diffuse large cell B-cell lymphoma","volume":"39","author":"Guzm\u00e1n Ortiz S.","year":"2020","unstructured":"Guzm\u00e1n Ortiz S., Mucientes Rasilla J., Vargas N\u00fa\u00f1ez J.A., Royuela A., Navarro Matilla B. and Mitjavila Casanovas M.: Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with 18F-FDG PET\/CT, in patients with diffuse large cell B-cell lymphoma. Rev Esp De Med Nucl e Imagen Mol (Engl Ed) 2020; 39: 340.","journal-title":"Rev Esp De Med Nucl e Imagen Mol (Engl Ed)"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s11307-020-01474-z","article-title":"Optimizing workflows for fast and reliable metabolic tumor volume measurements in diffuse large B cell lymphoma","volume":"22","author":"Burggraaff C.N.","year":"2020","unstructured":"Burggraaff C.N., Rahman F., Ka\u00dfner I., Pieplenbosch S., Barrington S.F., Jauw Y.W.S. et al: Optimizing workflows for fast and reliable metabolic tumor volume measurements in diffuse large B cell lymphoma. Mol Imaging Biol 2020; 22: 1102.","journal-title":"Mol Imaging Biol"},{"key":"e_1_3_5_44_2","first-page":"9","article-title":"A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET\/CT","author":"Gormsen L.C.","year":"2019","unstructured":"Gormsen L.C., Vendelbo M.H., Pedersen M.A., Haraldsen A., Hjorthaug K., Bogsrud T.V. et al: A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET\/CT. EJNMMI Res 2019; : 9.","journal-title":"EJNMMI Res"},{"key":"e_1_3_5_45_2","first-page":"45","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","author":"Ilyas H.","year":"2018","unstructured":"Ilyas H., Mikhaeel N.G., Dunn J.T., Rahman F., M\u00f8ller H., Smith D. et al: Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging 2018; : 45.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","unstructured":"Cottereau A.S. Hapdey S. Chartier L. Modzelewski R. Casasnovas O. Itti E. et al: Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. 2017; 58: 276.","DOI":"10.2967\/jnumed.116.180406"},{"key":"e_1_3_5_47_2","first-page":"41","article-title":"Metabolic tumour volumes measured at staging in lymphoma: Methodological evaluation on phantom experiments and patients","author":"Meignan M.","year":"2014","unstructured":"Meignan M., Sasanelli M., Casasnovas R.O., Luminari S., Fioroni F., Coriani C. et al: Metabolic tumour volumes measured at staging in lymphoma: Methodological evaluation on phantom experiments and patients. Eur J Nucl Med Mol Imaging 2014; : 41.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_48_2","article-title":"Quantitative oncology molecular analysis suite: ACCURATE","volume":"59","author":"Boellaard R.","year":"2018","unstructured":"Boellaard R.: Quantitative oncology molecular analysis suite: ACCURATE. J Nucl Med 2018; 59. 1753\u20131753.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00259-014-2783-x","article-title":"Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma","volume":"41","author":"Kanoun S.","year":"2014","unstructured":"Kanoun S., Rossi C., Berriolo-Riedinger A., Dygai-Cochet I., Cochet A., Humbert O. et al: Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2014; 41: 1735.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2967\/jnumed.121.263067","article-title":"The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in 18F-FDG PET scans of patients with classical Hodgkin lymphoma","volume":"63","author":"Driessen J.","year":"2022","unstructured":"Driessen J., Zwezerijnen G.J.C., Sch\u00f6der H., Drees E.E.E., Kersten M.J., Moskowitz A.J. et al: The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in 18F-FDG PET scans of patients with classical Hodgkin lymphoma. J Nucl Med 2022; 63: 1424.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1109\/TMI.2013.2263388","article-title":"Optimal Co-segmentation of tumor in PET-CT images with context information","volume":"32","author":"Song Q.","year":"2013","unstructured":"Song Q., Bai J., Han D., Bhatia S., Sun W., Rockey W. et al: Optimal Co-segmentation of tumor in PET-CT images with context information. IEEE Trans Med Imaging 2013; 32: 1685.","journal-title":"IEEE Trans Med Imaging"},{"key":"e_1_3_5_52_2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00259-020-05080-7","article-title":"Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET\/CT for total metabolic tumour volume prediction using a convolutional neural network","volume":"48","author":"Blanc-Durand P.","year":"2021","unstructured":"Blanc-Durand P., J\u00e9gou S., Kanoun S., Berriolo-Riedinger A., Bodet-Milin C., Kraeber-Bod\u00e9r\u00e9 F. et al: Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET\/CT for total metabolic tumour volume prediction using a convolutional neural network. Eur J Nucl Med Mol Imaging 2021; 48: 1362.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40336-021-00451-y","article-title":"The role of 18F-FDG PET\/CT radiomics in lymphoma","volume":"9","author":"Rizzo A.","year":"2021","unstructured":"Rizzo A., Triumbari E.K.A., Gatta R., Boldrini L., Racca M., Mayerhoefer M. et al: The role of 18F-FDG PET\/CT radiomics in lymphoma. Clin Transl Imaging 2021; 9: 589.","journal-title":"Clin Transl Imaging"},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phro.2021.10.007","article-title":"A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features","volume":"20","author":"Pfaehler E.","year":"2021","unstructured":"Pfaehler E., Zhovannik I., Wei L., Boellaard R., Dekker A., Monshouwer R. et al: A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features. Phys Imaging Radiat Oncol 2021; 20: 69.","journal-title":"Phys Imaging Radiat Oncol"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037023000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037023000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2023.01.023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:25:45Z","timestamp":1778268345000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2023.01.023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":53,"alternative-id":["10.1016\/j.csbj.2023.01.023"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2023.01.023","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2023.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}